SMOKING CESSATION

Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network

R Hubbard¹, S Lewis², J West¹, C Smith², C Godfrey³, L Smeeth⁴, P Farrington⁵, J Britton¹

¹ Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
² Division of Respiratory Medicine, University of Nottingham, Nottingham, UK
³ Centre for Health Economics, University of York, York, UK
⁴ Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, University of London, London, UK
⁵ Department of Statistics, Open University, Milton Keynes, UK

Correspondence to:
Dr R Hubbard
Clinical Sciences Building, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Richard.Hubbard{at}Nottingham.ac.uk

Background: Bupropion is an effective smoking cessation therapy but its use in the UK has been limited by concerns that it may increase the risk of sudden death.

Methods: Data for all patients prescribed bupropion within The Health Improvement Network (a computerised general practice database) were extracted and the self-controlled case-series method was used to estimate the relative incidence of death during the first 28 days of treatment. The incidence of seizures, a recognised adverse effect of bupropion, was also investigated during this period.

Results: A total of 9329 individuals had been prescribed bupropion (mean age 44 years, 48% male). The total person-time after the first prescription for bupropion was 17 586 years, and during this time 121 people died. Two people died within the first 28 days of treatment, which was less than expected in comparison with the remaining observation period by an incidence ratio of 0.50 (95% confidence interval (CI) 0.12 to 2.05). Twenty eight people were recorded as having a total of 45 seizures (23 before starting bupropion, two in the first 28 days of treatment, and 20 at a later point). The relative incidence of seizures during the first 28 days of treatment was 3.62 (95% CI 0.87 to 15.09), equivalent to one additional seizure per 6219 first time bupropion users.

Conclusions: Bupropion use is probably associated with an increased risk of seizures, but no evidence was found to suggest that the drug is associated with an increased risk of sudden death.

Keywords: bupropion; smoking cessation; seizures; sudden death; post-marketing surveillance

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Airwaves

Wisia Wedzicha
Thorax 2005 60: 793. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Martin-Merino, E., Ruigomez, A., Wallander, M.-A., Johansson, S., Garcia-Rodriguez, L. A. (2009). Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam Pract 0: cmp071v1-cmp071 [Abstract] [Full Text]  
• Gibson, J. E., Hubbard, R. B., Smith, C. J. P., Tata, L. J., Britton, J. R., Fogarty, A. W. (2009). Use of Self-controlled Analytical Techniques to Assess the Association Between Use of Prescription Medications and the Risk of Motor Vehicle Crashes. Am J Epidemiol 169: 761-768 [Abstract] [Full Text]  
• Whitaker, H. J, Hocine, M. N, Farrington, C P. (2009). The methodology of self-controlled case series studies. Stat Methods Med Res 18: 7-26 [Abstract]  
• Farrington, C. P., Whitaker, H. J., Hocine, M. N. (2009). Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 10: 3-16 [Abstract] [Full Text]  
• Breitling, L P, Twardella, D, Brenner, H (2008). High effectiveness of short treatment with bupropion for smoking cessation in general care. Thorax 63: 476-477 [Full Text]  
• Gulliford, M. C., Charlton, J., Latinovic, R. (2006). Risk of Diabetes Associated With Prescribed Glucocorticoids in a Large Population. Diabetes Care 29: 2728-2729 [Full Text]  
• Smeeth, L., Donnan, P. T, Cook, D. G (2006). The use of primary care databases: case-control and case-only designs. Fam Pract 23: 597-604 [Abstract] [Full Text]  
• Gulliford, M. C., Latinovic, R., Charlton, J., Hughes, R. A.C. (2006). Increased Incidence of Carpal Tunnel Syndrome up to 10 Years Before Diagnosis of Diabetes. Diabetes Care 29: 1929-1930 [Full Text]  
• Marcovitch, H. (2005). What's new this month in BMJ Journals. BMJ 331: 1168-1168 [Full Text]